Kura Oncology, Inc. (KURA) stock
KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.34−0.15 (-2.00%)
Close on Nov 18, 2026Market cap $652.97MP/E –Yield –
Kura Oncology cash
Cash and short-term investments held at the end of each period.
Kura Oncology's cash was $492.10M at Sep 30, 2026. For fiscal 2025 it was $667.24M, down 8.3% from the year before. Over ten years it grew 45.7% a year on average. The highest annual figure on record is $727.40M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $667.24M | -8.3% |
| FY2024 | Dec 31, 2024 | $727.40M | +71.6% |
| FY2023 | Dec 31, 2023 | $423.96M | -3.2% |
| FY2022 | Dec 31, 2022 | $437.99M | -15.4% |
| FY2021 | Dec 31, 2021 | $517.96M | -18.2% |
| FY2020 | Dec 31, 2020 | $633.32M | +167.3% |
| FY2019 | Dec 31, 2019 | $236.89M | +32.4% |
| FY2018 | Dec 31, 2018 | $178.99M | +92.2% |
| FY2017 | Dec 31, 2017 | $93.15M | +857.8% |
| FY2016 | Dec 31, 2016 | $9.73M | -37.0% |
| FY2015 | Dec 31, 2015 | $15.44M | +1273.9% |
| FY2014 | Dec 31, 2014 | $1.12M | +17013.3% |
| FY2013 | Dec 31, 2013 | $6.57K | +36.8% |
| FY2012 | Dec 31, 2012 | $4.80K | +13.8% |
| FY2011 | Dec 31, 2011 | $4.22K | -84.3% |
| FY2010 | Dec 31, 2010 | $26.90K | +141.4% |
| FY2009 | Dec 31, 2009 | $11.14K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $492.10M | -10.5% |
| Q2 FY2026 | Jun 30, 2026 | $519.03M | -17.7% |
| Q1 FY2026 | Mar 31, 2026 | $580.82M | -11.8% |
| Q4 FY2025 | Dec 31, 2025 | $667.24M | -8.3% |
| Q3 FY2025 | Sep 30, 2025 | $549.67M | +20.7% |
| Q2 FY2025 | Jun 30, 2025 | $630.73M | +28.3% |
| Q1 FY2025 | Mar 31, 2025 | $658.19M | +24.9% |
| Q4 FY2024 | Dec 31, 2024 | $727.40M | +71.6% |
| Q3 FY2024 | Sep 30, 2024 | $455.30M | +0.6% |
| Q2 FY2024 | Jun 30, 2024 | $491.52M | +3.0% |
| Q1 FY2024 | Mar 31, 2024 | $527.12M | +29.9% |
| Q4 FY2023 | Dec 31, 2023 | $423.96M | -3.2% |
| Q3 FY2023 | Sep 30, 2023 | $452.59M | +5.8% |
| Q2 FY2023 | Jun 30, 2023 | $476.98M | +5.9% |
| Q1 FY2023 | Mar 31, 2023 | $405.90M | -15.5% |
| Q4 FY2022 | Dec 31, 2022 | $437.99M | -15.4% |
| Q3 FY2022 | Sep 30, 2022 | $427.78M | -21.3% |
| Q2 FY2022 | Jun 30, 2022 | $450.26M | -20.7% |
| Q1 FY2022 | Mar 31, 2022 | $480.08M | -20.5% |
| Q4 FY2021 | Dec 31, 2021 | $517.96M | -18.2% |
| Q3 FY2021 | Sep 30, 2021 | $543.45M | +67.0% |
| Q2 FY2021 | Jun 30, 2021 | $567.49M | +67.5% |
| Q1 FY2021 | Mar 31, 2021 | $603.87M | +178.4% |
| Q4 FY2020 | Dec 31, 2020 | $633.32M | +167.3% |
| Q3 FY2020 | Sep 30, 2020 | $325.41M | +30.1% |
| Q2 FY2020 | Jun 30, 2020 | $338.87M | +29.6% |
| Q1 FY2020 | Mar 31, 2020 | $216.94M | +31.1% |
| Q4 FY2019 | Dec 31, 2019 | $236.89M | +32.4% |
| Q3 FY2019 | Sep 30, 2019 | $250.13M | +1116.1% |
| Q2 FY2019 | Jun 30, 2019 | $261.41M | +1380.4% |
| Q1 FY2019 | Mar 31, 2019 | $165.53M | +524.2% |
| Q4 FY2018 | Dec 31, 2018 | $178.99M | +92.2% |
| Q3 FY2018 | Sep 30, 2018 | $20.57M | -11.9% |
| Q2 FY2018 | Jun 30, 2018 | $17.66M | +45.3% |
| Q1 FY2018 | Mar 31, 2018 | $26.52M | +149.2% |
| Q4 FY2017 | Dec 31, 2017 | $93.15M | +857.8% |
| Q3 FY2017 | Sep 30, 2017 | $23.34M | – |
| Q2 FY2017 | Jun 30, 2017 | $12.15M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.73M | – |
See a number that looks wrong?